Literature DB >> 23126562

Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study.

C Wray1, J C Scovotti, J Tobis, C U Niemann, R Planinsic, A Walia, J Findlay, G Wagener, J B Cywinski, D Markovic, C Hughes, A Humar, A Olmos, R Sierra, R Busuttil, R H Steadman.   

Abstract

Over the last decade the age of liver transplant (LT) recipients and the likelihood of coronary artery disease (CAD) in this population have increased. There are no multicenter studies that have examined the impact of CAD on LT outcomes. In this historical cohort study, we identified adult LT recipients who underwent angiography prior to transplantation at seven institutions over a 12-year period. For each patient we recorded demographic data, recipient and donor risk factors, duration of follow-up, the presence of angiographically proven obstructive CAD (≥50% stenosis) and post-LT survival. Obstructive CAD was present in 151 of 630 patients, the CAD(+) group. Nonobstructive CAD was found in 479 patients, the CAD(-) group. Patient survival was similar for the CAD(+) group (adjusted HR 1.13, CI = [0.79, 1.62], p = 0.493) compared to the CAD(-) group. The CAD(+) patients were further stratified into severe (CADsev, >70% stenosis, n = 96), and moderate CAD (CADmod, 50-70% stenosis, n = 55) groups. Survival for the CADsev (adjusted HR = 1.26, CI = [0.83, 1.91], p = 0.277) and CADmod (adjusted HR = 0.93, CI = [0.52, 1.66], p = 0.797) groups were similar to the CAD(-) group. We conclude that when current CAD treatment strategies are employed prior to transplant, post-LT survival is not significantly different between patients with and without obstructive CAD. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2012        PMID: 23126562     DOI: 10.1111/j.1600-6143.2012.04293.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  22 in total

1.  Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.

Authors:  Sanjaya K Satapathy; Jason M Vanatta; Ryan A Helmick; Albert Flowers; Satish K Kedia; Yu Jiang; Bilal Ali; James Eason; Satheesh P Nair; Uzoma N Ibebuogu
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 2.  Role of cardiovascular intervention as a bridge to liver transplantation.

Authors:  Zankhana Raval; Matthew E Harinstein; James D Flaherty
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  The relationship between coronary artery disease and cardiovascular events early after liver transplantation.

Authors:  Samarth S Patel; Fei-Pi Lin; Viviana A Rodriguez; Chandra Bhati; Binu V John; Taylor Pence; Mohammad B Siddiqui; Adam P Sima; Antonio Abbate; Trevor Reichman; Mohammad S Siddiqui
Journal:  Liver Int       Date:  2019-03-26       Impact factor: 5.828

Review 4.  Liver Transplantation in the Obese Cirrhotic Patient.

Authors:  Erin K Spengler; Jacqueline G O'Leary; Helen S Te; Shari Rogal; Anjana A Pillai; Abdullah Al-Osaimi; Archita Desai; James N Fleming; Daniel Ganger; Anil Seetharam; Georgios Tsoulfas; Martin Montenovo; Jennifer C Lai
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

5.  Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia.

Authors:  Faisal A Abaalkhail; Mohammed I Al Sebayel; Mohammed A Shagrani; Wael A O'Hali; Nasser M Almasri; Abduljaleel A Alalwan; Mohammed Y Alghamdi; Hamad Al-Bahili; Mohammed S AlQahtani; Saleh I Alabbad; Waleed K Al-Hamoudi; Saleh A Alqahtani
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

6.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

7.  The predictors of post-transplant coronary events among liver transplant recipients.

Authors:  Mohammad U Malik; Stuart D Russell; Aliaksei Pustavoitau; Matthews Chacko; Arif M Cosar; Carol B Thompson; Panagiotis Trilianos; Nabil N Dagher; Andrew M Cameron; Ahmet Gurakar
Journal:  Hepatol Int       Date:  2016-06-16       Impact factor: 6.047

Review 8.  Cardiac imaging for the assessment of patients being evaluated for liver transplantation.

Authors:  Kameel Kassab; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2021-04-06       Impact factor: 3.872

9.  Time-varying impact of comorbidities on mortality after liver transplantation: a national cohort study using linked clinical and administrative data.

Authors:  Chutwichai Tovikkai; Susan C Charman; Raaj K Praseedom; Alexander E Gimson; Jan van der Meulen
Journal:  BMJ Open       Date:  2015-05-14       Impact factor: 2.692

10.  Effectively Screening for Coronary Artery Disease in Patients Undergoing Orthotopic Liver Transplant Evaluation.

Authors:  Bryan C Lee; Feng Li; Adam J Hanje; Khalid Mumtaz; Konstantinos D Boudoulas; Scott M Lilly
Journal:  J Transplant       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.